SourceBio International PLC Director/PDMR Shareholding (6179Q)
28 October 2021 - 11:55PM
UK Regulatory
TIDMSBI
RNS Number : 6179Q
SourceBio International PLC
28 October 2021
28 October 2021
SourceBio International plc
(" SourceBio", the "Company" or the "Group")
Director/PDMR Shareholding
SourceBio International plc has been notified that on 20 October
2021, Harwood Capital LLP made the following notifiable
transactions; (i) Harwood Capital LLP transferred 5,453,161 and
655,164 ordinary shares of 0.15 pence each in the Company
("Ordinary Shares") to Oryx International Growth Fund Limited
("Oryx") and North Atlantic Smaller Companies Investment Trust plc
("NASCIT"), respectively; and (ii) Harwood Capital LLP disposed of
1,399,517 Ordinary Shares.
Christopher Mills, Non-Executive Director of the Company is
Chief Executive of Harwood Capital LLP and has control of
investment decisions in relation to Oryx and NASCIT. Following the
transactions, Harwood Capital LLP and Christopher Mills are
beneficially interested in 20,275,680 Ordinary Shares, representing
27.3% of the issued share capital of the Company.
Notification and public disclosure of transactions by persons
discharging managerial responsibilities and persons closely
associated with them
1 Details of the person discharging managerial responsibilities
/ person closely associated
a) Name
Harwood Capital LLP and Harwood Management
(Gibraltar) Ltd, investment managers
--------------------------------------- --------------------------------------------------
2 Reason for the notification
-------------------------------------------------------------------------------------------
a) Position/status Christopher Mills is a non-executive
director of the issuer and Chief
Executive of the investment managers
--------------------------------------- --------------------------------------------------
b) Initial notification Initial Notification
/Amendment
--------------------------------------- --------------------------------------------------
3 Details of the issuer, emission allowance market participant,
auction platform, auctioneer or auction monitor
-------------------------------------------------------------------------------------------
a) Name SourceBio International Plc
--------------------------------------- --------------------------------------------------
b) LEI 213800KY4C9WU7WBW518
--------------------------------------- --------------------------------------------------
4 Details of the transaction(s): section to be repeated
for (i) each type of instrument; (ii) each type of transaction;
(iii) each date; and (iv) each place where transactions
have been conducted
-------------------------------------------------------------------------------------------
a) Description of the Ordinary shares of GBP0.0015 each
financial instrument,
type of instrument
Identification code GB00BKSB1674
b) Nature of the transaction (i) Transfer of shares
(ii) Disposal of shares
--------------------------------------- --------------------------------------------------
c) Price(s) and volume(s) (i)
---------------------- -----------------------
Price(s) Volume(s)
---------------------- -----------------------
Nil 5,453,161
---------------------- -----------------------
Nil 655,164
---------------------- -----------------------
(ii)
---------------------- -----------------------
Price(s) Volume(s)
---------------------- -----------------------
125.00p 1,339,517
---------------------- -----------------------
d) Aggregated information
- Aggregated volume (i)
- Price 6,108,325
Nil
(ii)
N/A - Single transaction
e) Date of the transaction 20 October 2021
f) Place of the transaction London Stock Exchange
--------------------------------------- --------------------------------------------------
This information is provided by RNS, the news service of the
London Stock Exchange. RNS is approved by the Financial Conduct
Authority to act as a Primary Information Provider in the United
Kingdom. Terms and conditions relating to the use and distribution
of this information may apply. For further information, please
contact rns@lseg.com or visit www.rns.com.
RNS may use your IP address to confirm compliance with the terms
and conditions, to analyse how you engage with the information
contained in this communication, and to share such analysis on an
anonymised basis with others as part of our commercial services.
For further information about how RNS and the London Stock Exchange
use the personal data you provide us, please see our Privacy
Policy.
END
DSHFLFSFIDLTFIL
(END) Dow Jones Newswires
October 28, 2021 08:55 ET (12:55 GMT)
Sourcebio (LSE:SBI)
Historical Stock Chart
From Nov 2024 to Dec 2024
Sourcebio (LSE:SBI)
Historical Stock Chart
From Dec 2023 to Dec 2024
